Hydrochlorothiazide: Dose, Frequency, Indications and more

Dosage and Frequency:

  • The usual dose of hydrochlorothiazide varies depending on the condition being treated.
  • For hypertension, the typical starting dose is 12.5 to 25 mg once daily, which can be increased up to 50 mg/day if needed.
  • For edema, the initial dose is typically 25 to 100 mg once daily or on alternate days, depending on the patient’s response.
  • The dose may need adjustment based on individual response and tolerability.

Route of Administration (ROA):

  • Hydrochlorothiazide is usually administered orally, in the form of tablets or capsules.

Mechanism of Action (MOA):

  • Hydrochlorothiazide is a thiazide diuretic that inhibits sodium reabsorption in the distal convoluted tubules of the kidneys, leading to increased excretion of sodium and water.

Pharmacokinetics (PK):

  • Hydrochlorothiazide is well absorbed orally, with peak plasma concentrations reached within 2 hours after ingestion.
  • It has a half-life of about 6 to 15 hours and is primarily excreted unchanged in the urine.

Pharmacodynamics (PD):

  • Hydrochlorothiazide acts on the kidneys to increase urine production and decrease extracellular fluid volume, resulting in decreased blood pressure and reduced edema.

Pathophysiology:

  • Hypertension: Hydrochlorothiazide helps lower blood pressure by reducing the volume of fluid in the bloodstream, thereby decreasing cardiac output and peripheral resistance.
  • Edema: By increasing urine production, hydrochlorothiazide helps remove excess fluid from the body, reducing swelling and edema.

Indications:

  • Treatment of hypertension (alone or in combination with other antihypertensive agents).
  • Management of edema associated with congestive heart failure, hepatic cirrhosis, or renal dysfunction.

Contraindications:

  • Hypersensitivity to hydrochlorothiazide or other sulfonamide-derived drugs.
  • Anuria.
  • Severe renal impairment.
  • Refractory hypokalemia or hyponatremia.
  • Severe hepatic impairment.

Drug Interactions:

  • Hydrochlorothiazide may interact with other antihypertensive medications, leading to additive effects on blood pressure.
  • Concomitant use with lithium, nonsteroidal anti-inflammatory drugs (NSAIDs), or corticosteroids may increase the risk of electrolyte imbalances.
  • Co-administration with digoxin may potentiate the risk of hypokalemia and cardiac arrhythmias.

Precautions:

  • Electrolyte Imbalance: Monitor serum electrolytes regularly, especially potassium levels, as hydrochlorothiazide can cause hypokalemia and hyponatremia.
  • Renal Impairment: Use caution in patients with renal dysfunction, as hydrochlorothiazide may further impair renal function.
  • Hepatic Impairment: Use with caution in patients with severe hepatic impairment, as hydrochlorothiazide metabolism may be altered.
  • Photosensitivity: Hydrochlorothiazide can increase the risk of sunburn, so patients should avoid prolonged sun exposure and use sunscreen.
  • Pregnancy and Lactation: Use during pregnancy or breastfeeding only if the potential benefit justifies the potential risk to the fetus or infant.

Monitoring and Laboratory Tests:

  • Monitor blood pressure regularly to assess the effectiveness of hydrochlorothiazide in managing hypertension.
  • Periodic monitoring of serum electrolytes, including potassium and sodium levels, is recommended to detect electrolyte imbalances.
  • Assess renal function through periodic measurement of serum creatinine and monitoring for signs of renal dysfunction.